These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 32492247

  • 1. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.
    Djordjevic DB, Tasic IS, Kostic ST, Stamenkovic BN, Lovic MB, Djordjevic ND, Koracevic GP, Lovic DB.
    Clin Cardiol; 2020 Sep; 43(9):1017-1023. PubMed ID: 32492247
    [Abstract] [Full Text] [Related]

  • 2. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C.
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 5. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J, Yamanaka Y, Watanabe S, Toba A, Harada K.
    Hypertens Res; 2019 Apr 17; 42(4):541-548. PubMed ID: 30542082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Apr 17; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Left ventricular hypertrophy in hemodialysis patient: Prevalence, electrocardiographic, echocardiographic study and associated risk factors].
    Chargui S, Allouche E, Dkhil W, Agrebi S, Ben Ahmed H, Ezzaouia K, Hajji M, Ezzamouri A, Basdah L, Ben Hamida F, Harzallah A, Abderrahim E.
    Nephrol Ther; 2022 Jul 17; 18(4):247-254. PubMed ID: 35078738
    [Abstract] [Full Text] [Related]

  • 11. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug 17; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Aug 17; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 14. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
    Yi S, Wang F, Wan M, Yi X, Zhang Y, Sun S.
    J Electrocardiol; 2020 Aug 17; 61():27-31. PubMed ID: 32504899
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov 17; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.